Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akero Therapeutics, Inc. | Chief Technology Officer | Common Stock | 24.3K | $756K | $31.10 | Dec 16, 2024 | Direct |
Akero Therapeutics, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 73.7K | Dec 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AKRO | Akero Therapeutics, Inc. | Dec 16, 2024 | 2 | $0 | 4 | Dec 18, 2024 | Chief Technology Officer |
AKRO | Akero Therapeutics, Inc. | Apr 29, 2024 | 1 | $0 | 4 | May 1, 2024 | Chief Technology Officer |
AKRO | Akero Therapeutics, Inc. | Apr 29, 2024 | 0 | $0 | 3 | May 1, 2024 | Chief Technology Officer |